Normal gonadal differentiation and sex development depend on the meticulous choreography and synchrony of a network of endocrine, paracrine, and autocrine signaling pathways reflecting the actions and interactions of specific genes, transcription factors, and hormones. Perturbations of this rather intricate network of gene regulation and gene expression governing fetal gonadal development result in disorders of sex development (DSDs). Approximately 1 in 4000 infants worldwide is born with a DSD.[1](#ped412012-bib-0001){ref-type="ref"} These disorders in DSD include a spectrum of abnormalities in which chromosomal, genetic, gonadal, and hormonal or anatomic aspects of sex are atypical.

The research report by Di Wu and colleagues focused on children with 46,XY DSD. From a single site in China, these investigators were able to establish data on 571 children with 46,XY non‐congenital adrenal hyperplasia (CAH) DSD. This is the largest series ever published to my knowledge presenting growth data and HCG stimulation test data and comparing height data to human chorionic gonadotrophin (HCG) response data. The investigators were able to establish precise etiologic diagnosis in a large number of children with 46,XY DSD: 5α‐reductase deficiency in 19 cases and androgen insensitivity syndrome in 28 children.

Based on this carefully selected cohort of patients with DSD, the authors were able to conduct HCG stimulation tests in this large cohort and establish reference growth data based on the testosterone response after HCG stimulation. These data will provide data to correctly interpret growth data in children with 46,XY DSD with regard to their testosterone response. After these auxological studies, the investigator scan next addresses glycolipid metabolism, bone development, psychological issue, and sexuality, and the research data on growth provide the fundamental start.

These studies confirm that androgens play an important role in growth and development from the fetal period.[2](#ped412012-bib-0002){ref-type="ref"} 46,XY DSDs are a class of diseases, and patients with different causes of 46,XY DSD may have a similar clinical phenotype. Due to differences in the severity of testosterone deficiency, growth curves may differ.

The data in this study show further that growth and development of patients with 46,XY DSD lags slightly behind that of normal children in infancy and childhood, especially in those children who had a poor testosterone response after HCG.

The landmark data compiled by Di Wu and colleagues provide much‐needed reference data to compare developmental patterns in children with 46,XY DSD.[3](#ped412012-bib-0003){ref-type="ref"}
